Fiche société
Medtronic Cardiac Ablation Solutions
Traitements, essais et publications liés.
Traitements6programmes
Essais3liés
Publications0liées
SourceDBlocale
Traitements
6| Molécule | Indication / population | Phase | Objectif | Pays | Résultat |
|---|---|---|---|---|---|
| Arctic Front™ Cardiac Cryoablation CatheterThe STOP AF First PAS is a prospective, global, multi-center, observational trial. | Maladie coronarienne | À vérifier | À vérifier | United States | À vérifier |
| Arctic Front™ Cardiac Cryoablation Catheter SystemThe STOP Persistent AF Post Approval Study (PAS) is a prospective, global, multicenter, observational trial. | Maladie coronarienne | À vérifier | À vérifier | United States, Austria, Germany, Italy, Poland, United Kingdom | À vérifier |
| Sphere-360 Pulsed Field Ablation Catheter with the Affera Mapping and Ablation SystemThe study is a prospective, single-arm, pre-market clinical study and will enroll up to 300 subjects at up to 26 sites in the United States (US) for analysis of primary objectives. No single site may contribute more than 15% of the enrollments. | Maladie coronarienne | Non applicable | À vérifier | United States | À vérifier |
| Arctic Front™ Cardiac Cryoablation Catheter SystemThe STOP Persistent AF Post Approval Study (PAS) is a prospective, global, multicenter, observational trial. | Maladie coronarienne | À vérifier | À vérifier | United States, Austria, Germany, Italy, Poland, United Kingdom | À vérifier |
| Arctic Front™ Cardiac Cryoablation CatheterThe STOP AF First PAS is a prospective, global, multi-center, observational trial. | Maladie coronarienne | À vérifier | À vérifier | United States | À vérifier |
| Sphere-360 Pulsed Field Ablation Catheter with the Affera Mapping and Ablation SystemThe study is a prospective, single-arm, pre-market clinical study and will enroll up to 300 subjects at up to 26 sites in the United States (US) for analysis of primary objectives. No single site may contribute more than 15% of the enrollments. | Maladie coronarienne | Non applicable | À vérifier | United States | À vérifier |
Essais cliniques
3| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Sphere-360 Pulsed Field Ablation Catheter with the Affera Mapping and Ablation System | Maladie coronarienne | Non applicable | NCT07308847 | Horizon 360 Protocol for the Treatment of Paroxysmal Atrial Fibrillation With the Sphere-360™ Catheter and Affera™ Mapping and Ablation System (Horizon 360) | ACTIVE_NOT_RECRUITING |
| Arctic Front™ Cardiac Cryoablation Catheter | Maladie coronarienne | À vérifier | NCT05227053 | STOP AF First Post-Approval Study | COMPLETED |
| Arctic Front™ Cardiac Cryoablation Catheter System | Maladie coronarienne | À vérifier | NCT05005949 | STOP Persistent AF PAS | ACTIVE_NOT_RECRUITING |
Publications
0| Molécule | Indication / population | Titre | Journal | Date |
|---|---|---|---|---|
| Aucune publication. | ||||